Patents Assigned to SOURCE PRECISION MEDICINE, INC d/b/a SOURCE MDX
  • Gene Expression Profiling for Identification, Monitoring and Treatment of Prostate Cancer
    Publication number: 20100233691
    Abstract: A method is provided in various embodiments for determining a profile data set for a subject with prostate cancer or conditions related to prostate cancer based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least 1 constituent from Tables 1-4. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that are substantially repeatable.
    Type: Application
    Filed: November 6, 2007
    Publication date: September 16, 2010
    Applicant: SOURCE PRECISION MEDICINE, INC. d/b/a SOURCE MDX
    Inventors: Danute M. Bankaitis-Davis, Lisa Siconolfi, Kathleen Storm, Karl Wassmann
  • Gene Expression Profiling for Identification, Monitoring and Treatment of Ovarian Cancer
    Publication number: 20100216137
    Abstract: A method is provided in various embodiments for determining a profile data set for a subject with ovarian cancer or conditions related to ovarian cancer based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least 1 constituent from Tables 1-5. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that are substantially repeatable.
    Type: Application
    Filed: November 6, 2007
    Publication date: August 26, 2010
    Applicant: Source Precision Medicine, Inc d/b/a Source MDX
    Inventors: Danute Bankaitis-Davis, Lisa Siconolfi, Kathleen Storm, Karl Wassmann
  • Gene Expression Profiling for Identification, Monitoring and Treatment of Lung Cancer
    Publication number: 20100184034
    Abstract: A method is provided in various embodiments for determining a profile data set for a subject with lung cancer or conditions related to lung cancer based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least 1 constituent from Tables 1-5. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that arc substantially repeatable.
    Type: Application
    Filed: November 6, 2007
    Publication date: July 22, 2010
    Applicant: SOURCE PRECISION MEDICINE, INC d/b/a SOURCE MDX
    Inventors: Danute M. Bankaitis-Davis, Kathleen Storm, Karl Wassmann, Lisa Siconolfi